ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Cell and Gene Therapy Conference, London, UK – pharmaphorum

pharmaphorumCell and Gene Therapy Conference, London, UKpharmaphorumCell and gene therapeutics have revolutionised modern medicine and have marked a new generation in biomedical and agricultural sciences. The latest developments in cell and gene therap… Continue reading

2018-05-01 Michael Zand NEWS

Engineers discover geometric underpinnings of T-cell stimulation through precise engineering of T-cell receptor … – Science Daily

Science DailyEngineers discover geometric underpinnings of T-cell stimulation through precise engineering of T-cell receptor …Science DailyWith the specific knowledge of the geometric parameters underlying T-cell receptor triggering, researchers coul… Continue reading

2018-05-01 Michael Zand NEWS

Merck, riding clinical success, eyes cancer immunotherapy lead – BioPharma Dive

Continue reading

2018-05-01 Michael Zand NEWS

Merck, riding clinical success, eyes cancer immunotherapy lead – BioPharma Dive


Miami Herald

Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive
Merck & Co.’s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma’s top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of …
Merck lifts earnings forecast after currency boostFinancial Times

all 101 news articles »

Continue reading

2018-05-01 Michael Zand NEWS

Gene therapy for lipoprotein lipase deficiency yields promising results – EurekAlert (press release)

EurekAlert (press release)Gene therapy for lipoprotein lipase deficiency yields promising resultsEurekAlert (press release)New Rochelle, NY, May 1, 2018–During the first 18 months after treatment with ali-pogene tiparvovec, a gene therapy recently app… Continue reading

2018-05-01 Michael Zand NEWS

Five amazing ways redesigning biological cells could help us fight cancer – The Conversation UK

The Conversation UKFive amazing ways redesigning biological cells could help us fight cancerThe Conversation UKCancer is the leading cause of death in the world. It occurs when mutations in our cells lead to unchecked growth. But what if we could engin… Continue reading

2018-05-01 Michael Zand NEWS

UC vs. Harvard: Round 2 in CRISPR gene technology fight – Eureka Times Standard


Miami Herald

Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive
Merck & Co.’s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma’s top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of …
Merck lifts earnings forecast after currency boostFinancial Times

all 101 news articles »

Continue reading

2018-05-01 Michael Zand NEWS

UC vs. Harvard: Round 2 in CRISPR gene technology fight – Santa Cruz Sentinel


Eureka Times Standard

UC vs. Harvard: Round 2 in CRISPR gene technology fight
Eureka Times Standard
It’s a high stakes showdown over intellectual-property rights between two of the nation’s most prestigious institutions, with perhaps a billion dollars in the balance. While research universities often reach settlements over patent disputes, both sides …

Continue reading

2018-05-01 Michael Zand NEWS
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Scientific American

UC vs. Harvard: Round 2 in CRISPR gene technology fight
Santa Cruz Sentinel
It’s a high stakes showdown over intellectual-property rights between two of the nation’s most prestigious institutions, with perhaps a billion dollars in the balance. While research universities often reach settlements over patent disputes, both sides …
All You Need to Know for Round 2 of the CRISPR Patent FightScientific American
UC vs. Harvard: Round 2 in CRISPR fightThe Mercury News
UC fights for CRISPR patent rights against Broad Institute, Harvard …Daily Californian

all 22 news articles »